VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Dear Friend;

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon May 13, 2024 9:38am

53 Views

Post# 36036576

RE:Dear Friend;

Good how well done Dr.G.Adams the visionary with Ventripoint good open 0.26$

 			@cardinal The 3m is an easy close. They could close more if they wanted to.
 			3
 			 				 						 							Share 						 							     					
 						 							Manage 						 							 Bookmark 					
 						 							Moderate 						 							 Flag  Ignore  Block 					
 			 		
 			35 minutes ago

Share
Manage	Bookmark
Moderate	Flag Ignore Block

 					 
@cardinalhugh is in Milan today for instance and Bob H is meeting with people on their timelines. Big interest from fantastic investor pool. These people are around the world and busy. This time its not a whack of 10k flippers
 			5
 			30 minutes ago

 					 
@JSSRDear Friend; Attached is today’s press release. Here is some background: 1. We announced April 11, 2024, a private placement of a convertible debenture financing for up to $3M at $0.25. 2. Today we announce the first tranche of that financing with gross proceeds of $941,000 with insider participation of $355,000 or 38% of this tranche. Thank you to those you who invested. 3. In addition, insiders have purchased 360,000 shares ninth market since the announcement of the private placement. 4. Obviously, we see a bright future for the company as our new sales approach of doing workshops at major conferences is working well. 5. We had 97 clinicians register for our workshops at the APEC con+ 102 more words. Click to expand
 			4
 			24 minutes ago

 					 
@cardinalthis insider group is putting their money where they mouths are now. Also, the groups that are taking part are key! Listen to what Bart is saying. He is a seriously seasoned med tech guy that chooses his words carefully. This share price is a gift

 			@cardinal The 3m is an easy close. They could close more if they wanted to.
 			3
 			 
 			35 minutes ago

 					 
@cardinal hugh is in Milan today for instance and Bob H is meeting with people on their timelines. Big interest from fantastic investor pool. These people are around the world and busy. This time its not a whack of 10k flippers
 			5
 			30 minutes ago

 					 
@JSSRDear Friend; Attached is today’s press release. Here is some background: 1. We announced April 11, 2024, a private placement of a convertible debenture financing for up to $3M at $0.25. 2. Today we announce the first tranche of that financing with gross proceeds of $941,000 with insider participation of $355,000 or 38% of this tranche. Thank you to those you who invested. 3. In addition, insiders have purchased 360,000 shares ninth market since the announcement of the private placement. 4. Obviously, we see a bright future for the company as our new sales approach of doing workshops at major conferences is working well.  5. We had 97 clinicians register for our workshops at the APEC con+ 102 more words. Click to expand
 			4
 			24 minutes ago

 					 
@cardinalthis insider group is putting their money where they mouths are now. Also, the groups that are taking part are key! Listen to what Bart is saying. He is a seriously seasoned med tech guy that chooses his words carefully. This share price is a gift